Sunday, February 15, 2026 2/15/2026

"Evaluating the role of monocytes in the development of an effective HIV vaccine response"

Award Number: F32AI181619
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 07/01/2024
PERIOD OF PERFORMANCE END DATE: 06/30/2027

Group Awards By:

View Award Description

"Evaluating the role of monocytes in the development of an effective HIV vaccine response" - Project Summary: The global epidemic of HIV continues to pose a major world health threat with more than 1.5 million new infections diagnosed in 2021. Although significant efforts have been underway for more than 30 years to develop a vaccine to prevent HIV infection, to date, only one trial has shown any significant efficacy at infection prevention. A recent study showed that monocyte gene enrichment correlated with the antibody dependent Fc effector functions thought to be the reason for this vaccine’s efficacy. Monocytes are highly versatile cells that regulate immune response through direct and indirect ways through secretion of cytokines. Monocytes are recognized for their ability to contribute to vaccine efficacy across multiple vaccines, including malaria, influenza and BCG. We hypothesize that monocyte subpopulations play a critical role in regulating development HIV vaccine elicited antibody response through innate help and that, once characterized, can be harnessed to improve vaccine efficacy. We will investigate this by two aims. Aim 1 will evaluate changes in monocyte gene expression following infection, auto-immune disease and vaccination using publicly available data and validate in healthy subjects an. Aim 2 will specifically identify monocyte sub-type specific signatures associated with antibody response after HIV vaccination from four recent HVTN trials using CITE-seq and a novel discrete-state mathematical algorithm with in vitro validation. Dr. Keefer and Dr. Thakar are the ideal mentors for this project given their expertise in HIV vaccine research and systems biology. Through this project, I will develop my computational and translational research and build a foundation from which I can transition to independence as a physician scientist.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $88,432 )
2025	2025	UNIVERSITY OF ROCHESTER	910 GENESEE ST	ROCHESTER	NY	14611	MONROE	USA	Allergy and Infectious Diseases Research	000	2	7/8/2025	NON-COMPETING CONTINUATION	$88,432
														Subtotal = $88,432

Issue Date FY: 2024 ( Subtotal = $85,864 )
2024	2024	UNIVERSITY OF ROCHESTER	910 GENESEE ST	ROCHESTER	NY	14611	MONROE	USA	Allergy and Infectious Diseases Research	002	1	5/13/2024	NEW	$0
2024	2024	UNIVERSITY OF ROCHESTER	910 GENESEE ST	ROCHESTER	NY	14611	MONROE	USA	Allergy and Infectious Diseases Research	001	1	5/13/2024	NEW	$5,312
2024	2024	UNIVERSITY OF ROCHESTER	910 GENESEE ST	ROCHESTER	NY	14611	MONROE	USA	Allergy and Infectious Diseases Research	000	1	3/25/2024	NEW	$80,552
														Subtotal = $85,864

Grand Total All Awards = $174,296

Top

All Categories

About

Search

Reports

Data Submission

Award Information

"Evaluating the role of monocytes in the development of an effective HIV vaccine response"

Award Number: F32AI181619

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 07/01/2024

PERIOD OF PERFORMANCE END DATE: 06/30/2027

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer